News
Nueva píldora contra obesidad de Novo Nordisk, Amycretin, supera a Wegovy en un ensayo inicial
La esperadísima nueva píldora contra la obesidad muestra un potencial para una mayor y más rápida pérdida de peso que Wegovy.
![[Fuente de la imagen: Getty Images]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/02/26112750/p-91498546-companies-do-not-want-to-pay-workers-for-their-ai-skills-even-though-they-want-them.webp)
![[Foto: Getty Images]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/02/26102748/accesibilidad-productos-Fast-Company-Mexico-Cortesia.webp)
![[Foto: gibblesmash asdf/Unsplash]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/02/26095341/p-1-91485413-Design-CN-If-technology-could-bring-traffic-fatalities-down-to-nearly-zero-why-not-embrace-it-.webp)
![[Ilustración de origen: Freepik]](https://fc-bucket-100.s3.amazonaws.com/wp-content/uploads/2026/02/26102314/p-91498688-video-podcasts.webp)
